Vaxcyte, Inc.

Q2 2020 13F Holders

Symbol
PCVX
CUSIP
92243G108
Type
Equity
Class
COM
Num filings
40
Total reported value, excl. options
$1.13 B
Manager Report Date Value ($000) Shares Option Type